Weekly Spotlight - 27.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Experts Debate Best Therapy Sequencing for Myeloma Patients

Experts discuss the optimal sequencing of therapies for multiple myeloma, weighing the benefits and risks of different treatment approaches, including the use of novel agents and combination therapies, to improve patient outcomes. The debate highlights the complexity and individualized nature of treatment decisions in multiple myeloma.

Using CAR-T Cell Therapy Earlier in Relapsed or Refractory Myeloma Treatment Shows Promise

Researchers are exploring the use of CAR-T cell therapy in earlier treatment stages for relapsed or refractory multiple myeloma, showing promising results in improving patient outcomes and potentially offering a new treatment option for this condition.

Improving Bispecific Therapy Transitions for Myeloma Patients: Unmet Needs and Future Directions

The article discusses unmet needs and future directions in enhancing bispecific therapy for multiple myeloma patients, particularly focusing on improving care transitions. It highlights the potential of bispecific antibodies to treat multiple myeloma and the need for better patient care coordination and support during treatment transitions.

DNA Testing Helps Identify Higher Risk and Best Treatment for Myeloma Patients

DNA testing can help identify patients with multiple myeloma who are at higher risk and may benefit from more aggressive treatment. This genetic information can guide doctors in choosing the best treatment options to improve patient outcomes.